Company intelligence / Profile preview

Asclepia MedChem Solutions

Destelbergen, Oost-Vlaanderen, Belgiumasclepia.com ↗

Ownership: Private
Development stage: Other

Overview

Asclepia MedChem Solutions is a Belgium-based CRO specializing in medicinal chemistry and drug discovery services. The company has contributed to the advancement of four new molecular entities into the clinic for inflammation, neuroscience, and oncology through collaborations with major pharmaceutical companies. It offers custom compound libraries, structure-based drug design, computational chemistry support, patent strategy consulting, due diligence assessments, grant application support, and competitive landscape analysis.

Therapeutic areas: OncologyImmunologyCardiovascularOphthalmologyNeurology
Modalities: Small moleculePeptides
Industry: Drug Discovery Services

Partnerships

IpsenUCBSanofiBristol Myers Squibb (BMS)ServieriTeos

Beyond the preview

Go deeper on Asclepia MedChem Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asclepia MedChem Solutions.

Explore the full profile